
    
      This is a single center, open-label study. The duration of the study will be 2 years. The
      number of targeted subjects will be 50 (in 2 years). We estimate that on average, the
      treatment duration is 4-8 weeks. Serum Glucan levels will be measured 2 times per week until
      the recovery of the infection or treatment end.
    
  